Evidence map›Paper›PMID 33692686›Full record

ArticleFrontiers in pharmacology2021

Yong Gu, Xi Chen, Shuping Fu, Wenlan Liu, Qi Wang, Ke-Jian Liu, Jiangang Shen

RetractedOpen access · goldAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Assessment of the Impact ofIranian journal of medical sciences · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. In Vitro and In Vivo Wound Healing Activity ofAdvances in pharmacological and pharmaceutical sciences · 2022
    Article
  6. Advances in pharmacological and pharmaceutical sciences · 2022
    Article
  7. Article
  8. Article
  9. Frontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

  • Retraction · 2023-07-03Concerns/Issues about Image · Duplication of/in Image · Investigation by Third Party · · see aslo: https://pubpeer.com/publications/662945ED8B85603D38D5F90A680EE8
  • Retracted
5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Yong GuClinical Research Center, Hainan Provincial Hospital of Chinese Medicine, Haikou, China.
Xi ChenDepartment of Core Facility, The People's Hospital of Bao-an Shenzhen, Shenzhen, China.
Shuping FuSchool of Chinese Medicine, University of Hong Kong, Hong Kong, China.
Wenlan LiuDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM, United States.
Qi WangInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, China.
Ke-Jian LiuDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM, United States.
Jiangang ShenSchool of Chinese Medicine, University of Hong Kong, Hong Kong, China.
University of Hong Kong · HKUniversity of New Mexico · USGuangzhou University of Chinese Medicine · CNHainan Provincial Hospital of Traditional Chinese Medicine · CNShenzhen Bao'an District People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isoflavones are major neuroprotective components of a medicinal herb

Indexed as

astragali radixestrogen receptorisoflavonesneuroprotectionsynergism

Identifiers

PMID33692686
PMCPMC7937971
OpenAlexW3132668933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.